SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-21-001151
Filing Date
2021-11-08
Accepted
2021-11-08 21:12:14
Documents
1
Period of Report
2021-11-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7115
  Complete submission text file 0000947871-21-001151.txt   8521
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 211389612

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences